相关实验视频
Updated: Jul 25, 2025

06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
662
在2型糖尿病中预测和预防心力衰竭
Ambarish Pandey1, Muhammad Shahzeb Khan2, Kershaw V Patel3
1Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
The lancet. Diabetes & endocrinology
|June 29, 2023
概括
心力衰竭是2型糖尿病患者日益关注的问题,导致健康状况较差. 本综述探讨了2型糖尿病患者心力衰竭的病理生理学,危险因素和预防策略.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
背景情况:
- 全球心力衰竭 (HF) 负担在2型糖尿病 (T2D) 患者中正在上升.
- 伴随性T2D和HF与显著更差的临床结果有关,包括增加住院治疗和死亡率.
- 优化HF预防策略对于这种高风险人群至关重要.
研究的目的:
- 阐明病理生理学,并确定T2D患者中HF的风险因素.
- 审查风险评估工具,以预测T2D中的HF发病率.
- 评估生活方式和药理干预措施对T2D中HF预防的有效性.
主要方法:
- 关于病理生理学,危险因素和临床试验数据的综合文献综述.
- 分析风险评估工具和管理策略.
- 讨论实施挑战和建议.
主要成果:
- 2型糖尿病通过复杂的病理生理机制显著增加心力衰竭的风险和严重程度.
- 几种风险因素有助于T2D中HF的发展,需要有针对性的评估.
- 临床试验表明,改变生活方式和特定的药理学药物的潜力有助于减轻HF风险.
结论:
- 了解T2D和HF之间的复杂联系对于有效的预防至关重要.
- 早期风险识别和量身定制的干预措施,包括改变生活方式和基于证据的药物,是关键.
- 解决实施障碍对于广泛采用改进的管理方法至关重要.
相关概念视频
Heart Failure V: Medical Management
15
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
15
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Heart Failure Drugs: Diuretics
424
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
424
Heart Failure VII: Nursing Interventions
100
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
100
Heart Failure II: Pathophysiology
16
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
467
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
467

